z-logo
open-access-imgOpen Access
A Comparison on Supervised and Semi-Supervised Machine Learning Classifiers for Gestational Diabetes Prediction
Author(s) -
Lokesh Kola
Publication year - 2021
Publication title -
international journal for research in applied science and engineering technology
Language(s) - English
Resource type - Journals
ISSN - 2321-9653
DOI - 10.22214/ijraset.2021.39434
Subject(s) - machine learning , artificial intelligence , gestational diabetes , diabetes mellitus , supervised learning , type 2 diabetes , disease , medicine , computer science , pregnancy , artificial neural network , gestation , endocrinology , biology , genetics
Diabetes is the deadliest chronic diseases in the world. According to World Health Organization (WHO) around 422 million people are currently suffering from diabetes, particularly in low and middle-income countries. Also, the number of deaths due to diabetes is close to 1.6 million. Recent research has proven that the occurrence of diabetes is likely to be seen in people aged between 18 and this has risen from 4.7 to 8.5% from 1980 to 2014. Early diagnosis is necessary so that the disease does not go into advanced stages which is quite difficult to cure. Significant research has been performed in diabetes predictions. As time passes, challenges keep increasing to build a system to detect diabetes systematically. The hype for Machine Learning is increasing day to day to analyse medical data to diagnose a disease. Previous research has focused on just identifying the diabetes without specifying its type. In this paper, we have we have predicted gestational diabetes (Type-3) by comparing various supervised and semi-supervised machine learning algorithms on two datasets i.e., binned and non-binned datasets and compared the performance based on evaluation metrics. Keywords: Gestational diabetes, Machine Learning, Supervised Learning, Semi-Supervised Learning, Diabetes Prediction

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here